Clinical Perspective of Antimicrobial Resistance in Bacteria

Ying Zhu; Wei E Huang; Qiwen Yang

doi:10.2147/IDR.S345574

Clinical Perspective of Antimicrobial Resistance in Bacteria

Infect Drug Resist. 2022 Mar 2:15:735-746. doi: 10.2147/IDR.S345574. eCollection 2022.

Authors

Ying Zhu^{1

2}, Wei E Huang³, Qiwen Yang¹

Affiliations

¹ Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
² Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
³ Department of Engineering Science, University of Oxford, Oxford, OX1 3PJ, UK.

Abstract

Antimicrobial resistance (AMR) has become a global clinical problem in recent years. With the discovery of antibiotics, infections were not a deadly problem for clinicians as they used to be. However, worldwide AMR comes with the overuse/misuse of antibiotics and the spread of resistance is deteriorated by a multitude of mobile genetic elements and relevant resistant genes. This review provides an overview of the current situation, mechanism, epidemiology, detection methods and clinical treatment for antimicrobial resistant genes in clinical important bacteria including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), penicillin-resistant Streptococcus pneumoniae (PRSP), extended-spectrum β-lactamase-producing Enterobacteriaceae, acquired AmpC β-lactamase-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae (CPE), multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa.

Keywords: antibiotic resistance mechanisms; antimicrobial resistant; detection methods; epidemiology; genes.

Publication types

Review